Chellapandian D, Chitty-Lopez M, Leiding JW (2020) Precision therapy for the treatment of primary immunodysregulatory diseases. Immunology and Allergy Clinics 40(3):511–526 (PMID: 32654696)

Article  Google Scholar 

Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C (2020) Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol 11:1–6. (PMID: 32048120; PMCID: PMC7082388)

Invitae. Test Catalog: Primary Immunodeficiency Gene Panel. Retrieved May 8, 2022, from https://www.invitae.com/en/providers/test-catalog/test-08100

Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, Keller M, Kobrynski LJ, Komarow HD, Mazer B, Nelson RP Jr (2015) Practice parameter for the diagnosis and management of primary immunodefieiency. Immunol Allergy Clin North Am 136(5):1186–1205

Article  Google Scholar 

Dorsey MJ, Dvorak CC, Cowan MJ, Puck JM (2017) Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening. J Allergy Clin Immunol 139(3):733–742. https://doi.org/10.1016/j.jaci.2017.01.005 (PMID: 28270365; PMCID: PMC5385855)

Article  PubMed  PubMed Central  Google Scholar 

Ballow M, Paris K, de la Morena M (2018) Should antibiotic prophylaxis be routinely used in patients with antibody-mediated primary immunodeficiency? J Allergy Clin Immunol Pract 6(2):421–426. https://doi.org/10.1016/j.jaip.2017.11.024 (Epub 2017 Dec 21. PMID: 29274825)

Eibl MM (2008) History of immunoglobulin replacement. Immunol Allergy Clin North Am 28(4):737–64, viii. https://doi.org/10.1016/j.iac.2008.06.004 (PMID: 18940572)

Cohn EJ (1945) Blood proteins and their therapeutic value. Science 101(2612):51–56. https://doi.org/10.1126/science.101.2612.51 (PMID: 17840912)

CAS  Article  PubMed  Google Scholar 

Cohn EJ, Luetscher JL, Oncley, SH et al (1940) Preparation and properties of serum and plasma proteins. III. Size and charge of proteins separating upon equilibration across membranes with ethanol - water mixtures of controlled pH, ionic strength and temperature. J Am Chem Soc 62(12):3396–3400. https://doi.org/10.1021/ja01869a032

Barandun S, Kistler P, Jeunet F, Isliker H (1962) Intravenous administration of human gamma-globulin. Vox Sang 7:157–174 (PMID: 13864762)

CAS  Article  Google Scholar 

Bruton OC (1952) Agammaglobulinemia. Pediatrics 9(6):722–728 (PMID: 14929630)

CAS  Article  Google Scholar 

MRC Working Party on Hypogammaglobuinaemia. Hypogammaglobulinaemia in the UK. London

Ochs HD, Buckley RH, Pirofsky B, Fischer SH, Rousell RH, Anderson CJ, Wedgwood RJ (1980) Safety and patient acceptability of intravenous immune globulin in 10% maltose. Lancet 2(8205):1158–1159 (PMID: 6107768)

CAS  Article  Google Scholar 

Centers for Disease Control and Prevention (CDC) (1999) Renal insufficiency and failure associated with immune globulin intravenous therapy - United States, 1985–1998. Morb Mortal Wkly Rep 48(24):518–21 (PMID: 10401909)

Wasserman RL (2019) Personalized therapy: immunoglobulin replacement for antibody deficiency. Immunol Allergy Clin North Am 39(1):95–111. https://doi.org/10.1016/j.iac.2018.08.001 (PMID: 30466775)

Article  PubMed  Google Scholar 

Sridhar G, Ekezue BF, Izurieta HS, Selvam N, Ovanesov MV, Divan HA, Liang Y, Golding B, Forshee RA, Anderson SA, Menis M (2014) Immune globulins and same-day thrombotic events as recorded in a large health care database during 2008–2012. Transfusion 54(10):2553–2565 (PMID: 24804899)

Article  Google Scholar 

Ochs HD, Gupta S, Kiessling P, Nicolay U, Berger M (2006) Subcutaneous IgG Study Group. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol 26(3):265–73. https://doi.org/10.1007/s10875-006-9021-7 (PMID: 16783465)

Wasserman RL, Melamed I, Stein MR, Gupta S, Puck J, Engl W, Leibl H, McCoy B, Empson VG, Gelmont D, Schiff RI; IGSC, 10% with rHuPH20 study group. Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency. J Allergy Clin Immunol. 2012 Oct;130(4):951–7.e11. https://doi.org/10.1016/j.jaci.2012.06.021 (Epub 2012 Jul 28. PMID: 22846381)

IG Therapy Products and Risk Factor Chart (2022) Immunoglobulin National Society. May 2, 2022, from https://ig-ns.org/product/ig-therapy-products-and-risk-factor-chart/

Orange JS, Grossman WJ, Navickis RJ, Wilkes MM (2010) Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 137(1):21–30. https://doi.org/10.1016/j.clim.2010.06.012 (Epub 2010 Aug 1. PMID: 20675197)

CAS  Article  PubMed  Google Scholar 

Bonagura VR, Marchlewski R, Cox A, Rosenthal DW (2008) Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol 122(1):210–212. https://doi.org/10.1016/j.jaci.2008.04.044 (PMID: 18602574)

CAS  Article  PubMed  Google Scholar 

Chan K, Puck JM (2005) Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115(2):391–398. https://doi.org/10.1016/j.jaci.2004.10.012 (PMID: 15696101)

Article  PubMed  Google Scholar 

Buckley RH (2012) The long quest for neonatal screening for severe combined immunodeficiency. J Allergy Clin Immunol 129(3):597–604; quiz 605–6. https://doi.org/10.1016/j.jaci.2011.12.964 (Epub 2012 Jan 24. PMID: 22277203; PMCID: PMC3294102)

Puck JM (2019) Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol Rev 287(1):241–252. https://doi.org/10.1111/imr.12729 (PMID: 30565242; PMCID: PMC6324582)

CAS  Article  PubMed  PubMed Central  Google Scholar 

Kwan A, Abraham RS, Currier R et al (2014) Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312(7):729–738. https://doi.org/10.1001/jama.2014.9132.Erratum.In:JAMA.2014Nov26;312(20):2169.Bonagura,VincentR[Added] (PMID: 25138334; PMCID: PMC4492158)

Article  PubMed  PubMed Central  Google Scholar 

Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2(7583):1366–1369. https://doi.org/10.1016/s0140-6736(68)92673-1 (PMID: 4177932)

CAS  Article  PubMed  Google Scholar 

Pai SY, Logan BR, Griffith LM, Buckley RH et al (2014) Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med 371(5):434–446. https://doi.org/10.1056/NEJMoa1401177 (PMID: 25075835; PMCID: PMC4183064)

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ et al (2010) Inborn errors working party of the european group for blood and marrow transplantation; european society for immunodeficiency. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 126(3):602–10.e1–11. https://doi.org/10.1016/j.jaci.2010.06.015 (Epub 2010 Jul 31. PMID: 20673987)

Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR et al (2012) Eurocord and inborn errors working party of european group for blood and marrow transplantation. Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood 119(12):2949–55. https://doi.org/10.1182/blood-2011-06-363572 (Epub 2012 Feb 3. PMID: 22308292)

Haddad E, Landais P, Friedrich W, Gerritsen B, Cavazzana-Calvo M, Morgan G, Bertrand Y, Fasth A, Porta F, Cant A, Espanol T, Müller S, Veys P, Vossen J, Fischer A (1998) Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 91(10):3646–3653 (PMID: 9573000)

CAS  PubMed  Google Scholar 

Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D, Davies GE, Gaspar HB, Veys PA (2005) Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 105(2):879–885. https://doi.org/10.1182/blood-2004-03-0960 (Epub 2004 Sep 14. PMID: 15367433)

CAS  Article  PubMed  Google Scholar 

Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR (2013) Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol 132(5):1150–1155 (Epub 2013 Jul 16. PMID: 23870668)

Article  Google Scholar 

Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D et al (2014) Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 383(9915):436–48. https://doi.org/10.1016/S0140-6736(13)62069-3 (Epub 2013 Oct 23. PMID: 24161820)

Pai SY (2019) Treatment of primary immunodeficiency with allogeneic transplant and gene therapy. Hematology Am Soc Hematol Educ Program 2019(1):457–465. https://doi.org/10.1182/hematology.2019000052 (PMID: 31808905; PMCID: PMC6913427)

Article  PubMed  PubMed Central  Google Scholar 

Penninger JM, Iriel-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ (2001) CD45: new jobs for an old acquaintance. Nat Immunol 2(5):389–396 (PMID: 11323691)

CAS  Article  Google Scholar 

Shamriz O, Chandrakasan S (2019) Update on advances in hematopoietic cell transplantation for primary immunodeficiency disorders. Immunology and Allergy Clinics 39(1):113–128 (PMID: 30466768)

Article  Google Scholar 

Bertaina A, Merli P, Rutella S, Pagliara D, Bernardo ME, Masetti R, Pende D, Falco M, Handgretinger R, Moretta F, Lucarelli B (2014) HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. Blood 124(5):822–826 (PMID: 24869942)

CAS  Article  Google Scholar 

Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, Rooney CM, Hanson IC, Krance RA, Shpall EJ, Cruz CR (2016) Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol 137(5):1498–505. (PMID: 26920464; PMCID: PMC4860050)

Fox TA, Booth C (2020) Gene therapy for primary immunodeficiencies. Br J Haematol. https://doi.org/10.1111/bjh.17269 (Epub ahead of print. PMID: 33336808)

Aiuti A, Ficara F, Cattaneo F, Bordignon C, Roncarolo MG (2003) Gene therapy for adenosine deaminase deficiency. Curr Opin Allergy Clin Immunol 3(6):461–466. https://doi.org/10.1097/00130832-200312000-00007 (PMID: 14612670)

CAS  Article  PubMed  Google Scholar 

Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J et al (1998) T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med 4(7):775–780. https://doi.org/10.1038/nm0798-775 (PMID:9662367; PMCID: PMC3777239)

CAS  Article  PubMed  PubMed Central  Google Scholar 

Aiuti A, Roncarolo MG, Naldini L (2017) Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products. EMBO Mol Med 9(6):737–740. https://doi.org/10.15252/emmm.201707573 (PMID:28396566; PMCID: PMC5452047)

CAS  Article  PubMed  PubMed Central  Google Scholar 

Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G et al (2019) Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med 380(16):1525–1534. https://doi.org/10.1056/NEJMoa1815408 (PMID: 30995372; PMCID: PMC6636624)

CAS  Article  PubMed  PubMed Central  Google Scholar